Jane Hollingsworth is co-founder and chief executive officer of NuPathe Inc., a Philadelphia-area specialty pharmaceutical company focused on the development and commercialization of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.
Prior to founding NuPathe, Jane was co-founder and executive vice president of Auxilium Pharmaceuticals, a specialty pharmaceutical company focused on urology and novel treatments. Before founding and launching two successful specialty pharmaceutical companies, Ms. Hollingsworth was vice president, secretary, and general counsel of IBAH, Inc., a multinational contract research organization that developed and obtained regulatory approval for pharmaceutical and biologic products. Jane started her career practicing law at the Philadelphia law firm of Montgomery, McCracken, Walker & Rhoads and served as law clerk to the Honorable Jane R. Roth of the United States District Court for the District of Delaware.
Jane is a leader in the life sciences industry and active in fostering entrepreneurship in a variety of industries. She also works with a number of organizations supporting her community and is thrilled to be in a position to help advance the mission of Breastcancer.org.
Jane lives in the Philadelphia area with her husband, Brad, and their three children.